All Stories

  1. In VitroDrug Combination Studies of Letermovir (AIC246, MK-8228) with Approved Anti-Human Cytomegalovirus (HCMV) and Anti-HIV Compounds in Inhibition of HCMV and HIV Replication

    Article • Antimicrobial Agents and Chemotherapy, March 2015, ASM Journals

    Dr Peter Lischka

  2. Geno- and Phenotypic Characterization of Human Cytomegalovirus Mutants SelectedIn Vitroafter Letermovir (AIC246) Exposure

    Article • Antimicrobial Agents and Chemotherapy, November 2013, ASM Journals

    Dr Peter Lischka